Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

339
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
339
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

414
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
414
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

438
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
438
Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

839
Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
839

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Standardized endpoint definitions for trials of transcatheter left atrial appendage closure: a consensus from the Left Atrial Appendage Academic Research Consortium†.

European heart journal·2026
Same author

Generalized Coronary Spasm after Pulsed Field Ablation: Not a device complication alone, but a possible interaction between technology and host biology.

Heart rhythm·2026
Same author

Influence of High-Frequency Low-Tidal Volume Versus Jet Ventilation on Acute and Long-Term Outcomes Following Pulmonary Vein Isolation.

Journal of cardiovascular electrophysiology·2026
Same author

Cardio Heart Connect: Protocol for a Randomized Trial of a Commercially Available mHealth Fitness Intervention for Cardiac Rehabilitation After Transcatheter Aortic Valve Replacement.

medRxiv : the preprint server for health sciences·2026
Same author

Transesophageal echocardiography versus fluoroscopy-guided left bundle branch area pacing: a comparative study.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing·2026
Same author

Pulsed-Field Ablation for Persistent Atrial Fibrillation: A Systematic Review and Meta-Analysis.

Journal of cardiovascular electrophysiology·2026

Related Experiment Video

Updated: Jan 17, 2026

Translational Rabbit Model of Chronic Cardiac Pacing
06:14

Translational Rabbit Model of Chronic Cardiac Pacing

Published on: January 6, 2023

3.1K

Risk Factors and Costs Associated With 1-Year Mortality and Readmission After Leadless Pacemaker Implantation.

Peter G Brodeur1, Enrico G Ferro1, Timothy G Maher2

  • 1Richard A. and Susan F. Smith Center for Outcomes Research, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA.

Pacing and Clinical Electrophysiology : PACE
|September 19, 2025
PubMed
Summary

High readmission rates for leadless pacemakers (LPM) significantly increase healthcare costs. Addressing heart failure (CHF) is key to improving outcomes and reducing costs associated with LPM complications.

Keywords:
costleadless pacemakersmortalityoutcomesreadmission

More Related Videos

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
16:40

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation

Published on: February 28, 2012

26.8K
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.6K

Related Experiment Videos

Last Updated: Jan 17, 2026

Translational Rabbit Model of Chronic Cardiac Pacing
06:14

Translational Rabbit Model of Chronic Cardiac Pacing

Published on: January 6, 2023

3.1K
A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
16:40

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation

Published on: February 28, 2012

26.8K
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.6K

Area of Science:

  • Cardiology
  • Health Economics
  • Medical Device Technology

Background:

  • Leadless pacemakers (LPM) offer a safe alternative to traditional transvenous pacing systems.
  • Limited data exists on post-implant complication rates and associated healthcare expenditures for LPM.
  • This study investigates risk factors, causes, and costs of 1-year mortality and readmissions following LPM implantation.

Purpose of the Study:

  • To assess risk factors for 1-year mortality and all-cause readmission after LPM implantation.
  • To identify the primary causes of readmission and in-hospital mortality.
  • To characterize the total healthcare costs associated with initial LPM procedures and subsequent readmissions.

Main Methods:

  • Utilized Healthcare Cost and Utilization Project data from Florida, Maryland, and New York (2016-2021).
  • Included inpatient and outpatient encounters for 7127 patients receiving LPM.
  • Employed Cox proportional hazards regression to identify risk factors for mortality and readmission, analyzing associated costs.

Main Results:

  • The 1-year all-cause readmission rate was 45.9%, with an 8.8% in-hospital mortality rate.
  • Comorbidities like heart failure (CHF), atrial fibrillation, chronic kidney disease, and diabetes significantly increased mortality and readmission risks.
  • CHF was the leading cause of readmission (17%), contributing to a 44.4% increase in total healthcare costs, reaching $257 million for index admissions.

Conclusions:

  • High healthcare expenditures are driven by substantial readmission and in-hospital mortality rates post-LPM implantation.
  • Readmissions represent a potentially modifiable target for cost reduction and outcome improvement.
  • CHF is a critical factor in adverse outcomes, highlighting the need for integrated care involving pacing strategies, medical therapy, and close monitoring.